Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Assessment of Microcirculation In Shock (DAMIS)

NCT04173221 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT04173221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Assessment of Microcirculation In Shock (DAMIS)
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2020
Completion date
August 30, 2022
Enrollment
141 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care, microcirculation, shock